No abstract is available for this article. Conflicts of Interest All authors declare no conflicts of interest. References 1 and , “Down Syndrome, Drug Metabolism and Chromosome 21,” Pediatric Blood & Cancer 44, no. 1 (2005): 33–39, https://doi.org/10.1002/pbc.20092. 2 and , “Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia,” Journal of Pediatric Hematology/Oncology 38, no. 4 (2016): 283–287, https://doi.org/10.1097/MPH.0000000000000540. 3.